Peter Kyle said he was willing to take on greater risk in approving the speedy financial support for carmakerRead More
You might also be interested in reading Terns Pharmaceuticals Selected for Oral Presentation at European Hematology Association Congress For Preclinical Data on Novel Allosteric BCR-ABL Inhibitor TERN-701.